JAKARTA (Reuters) – Indonesian President Joko Widodo received the nation’s first coronavirus vaccine live on television last month, but despite the fanfare, his ambitious inoculation campaign is already facing glitches from refrigeration, distrust and disinformation.FILE PHOTO: Indonesian healthcare workers are seen during verification and health screening before receiving Sinovac’s vaccine for the coronavirus disease (COVID-19)
Kinks in quickly established new production and distribution supply chains are a major reason why COVID-19 vaccines approved for use in the United States have been sluggish finding their way into people’s arms, says an expert in logistics and supply chains at The University of Alabama in Huntsville (UAH), a part of the University of
Iran’s ambassador to Russia said Saturday that Tehran expects to receive the first batch of Moscow’s Sputnik V coronavirus vaccine by February 4, state news agency IRNA reported. The news comes just days after Iran’s Foreign Minister Mohammad Javad Zarif announced the vaccine had been approved by the Islamic republic. “A contract for the purchase
ZURICH (Reuters) – Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.Slideshow ( 2 images )Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson
Moderna confirms it is on track to deliver 100 million vaccine doses to America by March and 200 million by June as Biden promises that anyone who wants a shot will have it in spring Moderna Inc says it is on track to deliver 100 million coronavirus vaccine doses by March and 200 million in June
The European Union on Tuesday warned pharmaceutical giants that develop coronavirus vaccines to honor their contractual obligations after slow deliveries of shots from two companies hampered the bloc’s vaunted vaccine rollout in several nations. The bloc already lashed out Monday at pharmaceutical company AstraZeneca, accusing it of failing to guarantee the delivery of coronavirus vaccines
HERO-TOGETHER, a new research study, will gain insights on how COVID-19 vaccination can help keep communities healthy and free of the virus. The COVID-19 pandemic is a once-in-a-generation challenge that healthcare heroes everywhere have worked together to face. From working on the front lines to working behind the scenes, people in health care and public
The World Health Organization said Wednesday that about 28 million vaccine doses have been administered so far in the fight against the COVID-19 pandemic—largely in the wealthiest countries. WHO emergencies director Michael Ryan said around 46 countries had started their coronavirus vaccination campaigns—of which 38 were high-income countries. “We’ve about 28 million vaccine doses that
The European Union’s medicines watchdog on Wednesday approved a second coronavirus vaccine, in a relief to struggling European countries as the world reached a grim new record of 15,700 deaths in 24 hours. The Moderna vaccine is now set to join Pfizer-BioNTech’s jab for use in the 27-nation EU, where governments are grappling with soaring
It has been clear for a while that, at least in the U.S., the only way out of the coronavirus pandemic will be through vaccination. The rapid deployment of coronavirus vaccines is underway, but how many people need to be vaccinated in order to control this pandemic? I am a computational biologist who uses data
As U.S. health officials try to get COVID-19 vaccines to people more quickly, it’s already time for some people to get their second shots. So who’s keeping track to make sure you get the correct second dose, and on time? And who can see that information? It’s one of the many logistical issues health officials
Two pharmaceutical companies say they’re ready to begin vaccinating people before the end of December, if their vaccines are authorized by the Food and Drug Administration. What does that mean? The two companies have applied to the FDA for emergency use authorization of their Covid-19 vaccines immediately. The FDA will meet on December 10 to
German pharmaceutical company BioNTech is confident that its coronavirus vaccine works against the new UK variant, but further studies are need to be completely sure, its chief executive said Tuesday. The variant, detected mainly in London and the southeast of England in recent weeks, has sparked concern worldwide because of signs that it may spread
Lost in the U.S. launch of the coronavirus vaccine is a fact most don’t know when they roll up their sleeves: In rare cases of serious illness from the shots, the injured are blocked from suing and steered instead to an obscure federal bureaucracy with a record of seldom paying claims. Housed in a nondescript
Seventy-one percent of the U.S. public report that they would definitely or probably get a COVID-19 vaccine, marking an increase from 63 percent in September, according to the ongoing research project, the KFF COVID-19 Vaccine Monitor. The KFF COVID-19 Vaccine Monitor used a combination of surveys and focus groups to track the U.S. public’s attitudes
Another day, another announcement about a COVID-19 vaccine. Whether that’s talk of results from clinical trials, emergency approval or plans for countries to prioritize certain groups for vaccination. But we still don’t know if current vaccines prevent disease and also prevent people transmitting the virus to others. This not only has implications for vaccines we’ve
American experts were set to discuss Thursday if Moderna’s COVID-19 vaccine should be authorized, as European nations vowed to get their coronavirus inoculation campaigns rolling before the end of the year. Surges in infections have prompted tighter restrictions in several European countries, while the United States—the worst-hit nation in the world—set a double record, with
People with serious mental illness should be given priority access to a COVID-19 vaccine when one becomes available, say University of Queensland researchers. Studies show people with serious mental illness are more likely to be infected by the COVID-19 virus and have higher rates of hospitalization due to medications, poorer general health, reduced access to
National efforts to develop a coronavirus disease 2019 (COVID-19) vaccine at “warp speed” will likely yield a safe and effective vaccine by early 2021. However, this important milestone is only the first step in an equally important challenge: getting a majority of the U.S. public vaccinated. Authors of a viewpoint article in the Journal of
When will the coronavirus vaccine reach the general public? Fox News medical contributor Dr. Janette Nesheiwat discusses the vaccine distribution timeline on ‘Fox & Friends First.’ The U.S. will administer its first doses of Pfizer’s recently approved coronavirus vaccine on Monday, Dec. 14, as part of a historic mass vaccination effort, while related deaths tick
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok